Shearman & Sterling advised Decisio Health, Inc. on its $13 million Series B financing led by GE Healthcare.

A Houston-based software company whose product is registered as an FDA-approved medical device, Decisio Health specializes in clinical surveillance to expand into the virtual care space and revolutionize patient monitoring. Decisio’s solutions provide a real-time, consolidated view of patients from multiple systems across a care area, hospital or an entire network.

The Team